```html

Bovine Spongiform Encephalopathy (Mad Cow Disease)

Overview

Bovine spongiform encephalopathy (BSE), commonly known as “mad cow disease,” is a progressive, fatal neurodegenerative disorder that affects cattle. It belongs to the family of prion diseases, which also includes Creutzfeldt‑Jakob disease (CJD) in humans, scrapie in sheep, and chronic wasting disease in deer.

• Who it affects: Primarily adult cattle (typically >4 years old). Humans who consume infected beef products can develop a variant form called vCJD, but this is extremely rare.
• Prevalence: The first recognized outbreak occurred in the United Kingdom in the mid‑1980s. Since aggressive feed‑ban policies were implemented, the number of confirmed BSE cases worldwide has dropped dramatically—from more than 180,000 cases reported globally between 1992‑2000 to fewer than 200 new cases per year in the most recent WHO report (2022). The United States has reported only a handful of confirmed BSE cases in cattle (four as of 2024) and no native vCJD cases.

Because prions are highly resistant to routine sterilization and heat, BSE poses unique challenges for food safety and public health.

Symptoms

Clinical signs in cattle appear after an incubation period that can last 2–8 years. Early symptoms are subtle and often mistaken for other neurologic disorders.

Early (Prodromal) Signs

• Changes in temperament: nervousness, aggression, or excessive fearfulness.
• Appetite loss: reduced feed intake without other gastrointestinal disease.
• Weight loss: despite a normal or reduced appetite.

Middle‑Stage Signs

• Ataxia: uncoordinated gait, stumbling, or difficulty rising.
• Hyperreactivity: exaggerated response to touch or sound.
• Polyuria/polydipsia: increased urination and drinking.
• Scratching or rubbing: typically on the head or neck.

Late (Advanced) Signs

• Stupor or coma: progressive loss of consciousness.
• Recumbency: inability to stand.
• Loss of bite reflex: difficulty chewing.
• Generalized tremors: fine or coarse shaking throughout the body.
• Death: usually occurs 2–12 months after symptom onset.

In humans with variant CJD (vCJD), symptoms include psychiatric disturbances, sensory changes, ataxia, and rapidly progressive dementia, typically developing 10–15 years after exposure.

Causes and Risk Factors

BSE is caused by an abnormal isoform of a normal cellular protein called a prion (PrP<sup>Sc</sup>). Unlike viruses or bacteria, prions contain no nucleic acids and propagate by inducing misfolding of normal prion proteins in the brain.

Primary Sources of Infection

• Contaminated feed: The most common route is the inclusion of meat‑and‑bone meal (MBM) made from the tissues of infected cattle or other ruminants.
• Maternal transmission: Rare but documented transmission from dam to calf through placental or colostral exposure.
• Environmental persistence: Prions can remain infective in soil for years, posing a low‑level risk to grazing cattle.

Risk Factors for Cattle

• Age > 4 years (longer incubation period).
• History of exposure to MBM or other animal‑protein supplements.
• Herds located in regions with previous BSE outbreaks.
• Breeding from a previously infected dam.

Risk Factors for Humans

• Consumption of high‑risk beef products (e.g., brain, spinal cord, or other nervous tissue) from infected cattle.
• Living in a country with a known BSE outbreak during the 1980s–1990s.
• Occupational exposure (veterinarians, abattoir workers) – although documented cases are exceedingly rare.

Diagnosis

Definitive diagnosis of BSE in cattle can only be made post‑mortem, but a combination of clinical suspicion, epidemiologic information, and laboratory testing guides decision‑making.

Ante‑mortem (Live Animal) Evaluation

• Clinical examination: neurologic assessment for ataxia, hyperreactivity, and other signs listed above.
• History: exposure to prohibited feed, age, and herd prevalence.

Post‑mortem Testing (Gold Standard)

1. Immunohistochemistry (IHC): Detects abnormal prion protein in the obex (brain stem) and other brain regions.
2. Western blot: Confirms the presence and molecular profile of PrP<sup>Sc</sup>.
3. Enzyme‑linked immunosorbent assay (ELISA): High‑throughput screening of brain tissue.
4. Real‑time quaking‑induced conversion (RT‑QuIC): Highly sensitive assay now used in some reference labs.

For suspected human vCJD, diagnostic work‑up includes:

• Neurological exam and detailed exposure history.
• Magnetic resonance imaging (MRI) – characteristic basal ganglia signal changes.
• Electroencephalography (EEG) – periodic sharp wave complexes (less common in vCJD).
• CSF analysis – presence of 14‑3‑3 protein (supportive, not definitive).
• Definitive diagnosis: brain biopsy or autopsy with IHC detection of PrP<sup>Sc</sup>.

Treatment Options

Currently, there is no cure for BSE in cattle or vCJD in humans. Management focuses on containment, supportive care, and preventing transmission.

For Affected Cattle

• Euthanasia: Recommended once BSE is suspected to prevent spread.
• Removal from food chain: All designated risk materials (DRM) – brain, spinal cord, eyes, and dorsal root ganglia – must be destroyed.
• Herd quarantine: Testing of neighboring animals and strict feed bans.

For Humans with vCJD

• Supportive care: Pain management, anti‑seizure medication, nutritional support, and physiotherapy.
• Experimental therapies: Trials of anti‑prion compounds (e.g., quinacrine, doxycycline) have not shown consistent benefit; they remain investigational.
• Psychosocial support: Counseling for patients and families is essential.

Lifestyle & Environmental Measures

• Strict adherence to feed‑ban regulations for cattle.
• Avoid consumption of high‑risk bovine tissues, especially from regions with known BSE cases.
• Follow occupational safety guidelines when handling potentially infected material.

Living with Bovine spongiform encephalopathy (Mad Cow Disease)

Although BSE in cattle is a veterinary issue, people who work with livestock may need coping strategies. Below are practical tips for farmers, veterinarians, and abattoir employees.

• Record‑keeping: Maintain detailed feed logs to prove compliance with ban on MBM.
• Personal protective equipment (PPE): Wear gloves, masks, and disposable gowns when conducting necropsies or handling brain/spinal tissue.
• Isolation protocol: Set aside a dedicated area for sick or suspect cattle to limit contact with the rest of the herd.
• Waste disposal: Use approved incineration or rendering methods for DRMs; never compost them.
• Emotional support: Seek veterinary extension services or peer support groups if dealing with a herd loss.

Prevention

Prevention is far more effective than treatment. Governmental policies, industry practices, and consumer awareness all play roles.

1. Feed bans: Prohibit the use of ruminant protein in cattle feed. Most countries have strict regulations enforced by agencies such as the USDA (USA), EFSA (EU), and CFIA (Canada).
2. Surveillance programs: Routine testing of fallen stock, emergency slaughter, and high‑risk herds. The World Organization for Animal Health (OIE) recommends a minimum of 0.1% testing in suspect animals.
3. Removal of DRMs: All high‑risk tissues must be removed at slaughter and destroyed.
4. Import controls: Ban or heavily limit beef products from regions with active BSE cases.
5. Public education: Inform consumers about safe cooking practices (though prions are heat‑resistant, avoiding high‑risk tissues is key).

Complications

If BSE is not identified and controlled, several serious complications can arise:

• Spread within herd: Infected cattle can transmit the disease to others via feed or environmental contamination.
• Economic loss: Culling, loss of market access, trade bans, and decreased consumer confidence can cost billions (the UK estimated £5 billion in the 1990s).
• Public‑health impact: Although rare, vCJD carries a mortality rate > 90% and can cause long‑term neurological disability.
• Legal consequences: Violations of feed bans or improper disposal can result in fines and criminal charges.

When to Seek Emergency Care

---

Sources: Mayo Clinic, Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), World Health Organization (WHO), World Organization for Animal Health (OIE), Cleveland Clinic, and peer‑reviewed articles from The Lancet and Journal of Virology (2023‑2024).

```